Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 1,975.60
+9.70 (0.49%)
Dec 4, 2025, 3:30 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 557.01 billion as of December 4, 2025. Its market cap has increased by 28.22% in one year.
Market Cap
557.01B
Enterprise Value
542.35B
Revenue
159.97B
Ranking
n/a
PE Ratio
55.16
Stock Price
1,975.60
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 557.01B, an increase of 48,364.84%. That is a compound annual growth rate of 28.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 554.78B | 22.18% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | 139.25B | 42.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.34T |
| Divi's Laboratories | 1.70T |
| Cipla | 1.24T |
| Apollo Hospitals Enterprise | 1.05T |
| Zydus Lifesciences | 942.29B |
| Mankind Pharma | 929.12B |
| Aurobindo Pharma | 712.47B |
| Fortis Healthcare | 683.12B |